AZ's Forxiga Gets Type 1 Diabetes EU Okay As Sanofi Suffers US Setback

 
• By Kevin Grogan

Forxiga is the first oral medicine approved in the EU as an adjunct to insulin for type 1 diabetes and the regulatory boost for AstraZeneca comes as Sanofi gets a CRL from the FDA for Zynquista.

sad - happy
Happy day for Astrazeneca, not so happy for Sanofi • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas